• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Quest for solution disinfectants


Care solutiosn play a major role in determining contact lens safety and comfort, and composition of the care product clearly matters.

Key Points

Salt Lake City-Care solutions play a major role in determining contact lens safety and comfort, and composition of the care product clearly matters. There remains, however, a need for well-designed research in many areas because there are many unanswered questions pertaining to how care solution ingredients affect the experience of contact lens wear, said Jason J. Nichols, OD, MPH, PhD, at Optometry's Meeting.

Getting the right mix

Formulation decisions on chemical disinfectants in care solutions are based on the goal of maintaining a balance between efficacy and safety, recognizing that while a higher concentration of a disinfectant will certainly be more effective in eradicating microbes, it could also be more damaging to the ocular surface.

"The aim is to avoid too much of a 'good thing' because that could induce a physiological response, such as discomfort, ocular surface staining, or inflammation," he said.

Controversies involving disinfectants relate to their efficacy-experts disagree over whether the chemical disinfectants used in multi-purpose solution (MPS), such as biguanides, polyquaternium-1, and myristamidopropyl dimethylamine, or hydrogen peroxide are more efficacious-but particularly to safety issues.

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.